tiprankstipranks
Naturhouse Health (ES:NTH)
BME:NTH
Spanish Market
NTH
Naturhouse Health
RESEARCH TOOLSreports

Naturhouse Health (NTH) Ratios

5 Followers

Naturhouse Health Ratios

ES:NTH's free cash flow for Q2 2025 was €0.73. For the 2025 fiscal year, ES:NTH's free cash flow was decreased by € and operating cash flow was €0.31. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.12 ― 4.36 2.69 3.23
Quick Ratio
 1.90 ― 3.83 2.48 2.91
Cash Ratio
 1.61 ― 3.20 1.91 1.44
Solvency Ratio
 0.47 ― 1.08 0.74 0.80
Operating Cash Flow Ratio
 0.70 ― 1.79 1.64 0.85
Short-Term Operating Cash Flow Coverage
 0.00 ― 93.98 145.49 21.84
Net Current Asset Value
€ 11.75M€ ―€ 17.27M€ 16.16M€ 12.11M
Leverage Ratios
Debt-to-Assets Ratio
 0.06 ― 0.10 0.10 0.13
Debt-to-Equity Ratio
 0.11 ― 0.13 0.16 0.19
Debt-to-Capital Ratio
 0.10 ― 0.12 0.14 0.16
Long-Term Debt-to-Capital Ratio
 0.04 ― 0.03 0.05 0.06
Financial Leverage Ratio
 1.69 ― 1.34 1.59 1.54
Debt Service Coverage Ratio
 61.73 ― 45.62 54.85 22.83
Interest Coverage Ratio
 80.83 ― 94.60 152.00 62.39
Debt to Market Cap
 <0.01 ― 0.01 0.02 0.02
Interest Debt Per Share
 0.05 ― 0.07 0.09 0.09
Net Debt to EBITDA
 -1.80 ― -1.05 -1.08 -0.43
Profitability Margins
Gross Profit Margin
72.34%―71.75%49.81%71.53%
EBIT Margin
28.76%―27.68%31.09%25.40%
EBITDA Margin
29.42%―31.63%35.58%29.78%
Operating Profit Margin
28.55%―26.60%32.27%24.53%
Pretax Profit Margin
29.75%―27.40%30.58%25.00%
Net Profit Margin
22.13%―19.96%22.40%18.37%
Continuous Operations Profit Margin
22.13%―19.96%22.31%18.36%
Net Income Per EBT
74.40%―72.83%73.26%73.47%
EBT Per EBIT
104.18%―102.99%94.78%101.95%
Return on Assets (ROA)
18.78%―23.16%23.12%22.48%
Return on Equity (ROE)
29.55%―31.13%36.87%34.62%
Return on Capital Employed (ROCE)
35.58%―36.39%45.07%37.34%
Return on Invested Capital (ROIC)
25.65%―25.79%31.56%26.25%
Return on Tangible Assets
18.93%―23.36%23.33%22.81%
Earnings Yield
5.12%―9.91%11.63%10.16%
Efficiency Ratios
Receivables Turnover
 13.28 ― 20.97 20.05 21.81
Payables Turnover
 2.20 ― 3.85 6.18 4.42
Inventory Turnover
 3.35 ― 4.05 9.19 5.59
Fixed Asset Turnover
 12.18 ― 14.83 13.75 13.17
Asset Turnover
 0.85 ― 1.16 1.03 1.22
Working Capital Turnover Ratio
 2.37 ― 2.28 2.50 2.19
Cash Conversion Cycle
 -29.11 ― 12.65 -1.12 -0.56
Days of Sales Outstanding
 27.49 ― 17.41 18.20 16.74
Days of Inventory Outstanding
 109.04 ― 90.06 39.72 65.29
Days of Payables Outstanding
 165.64 ― 94.82 59.04 82.59
Operating Cycle
 136.53 ― 107.47 57.92 82.03
Cash Flow Ratios
Operating Cash Flow Per Share
 0.16 ― 0.19 0.35 0.12
Free Cash Flow Per Share
 0.15 ― 0.19 0.34 0.10
CapEx Per Share
 0.01 ― <0.01 <0.01 0.02
Free Cash Flow to Operating Cash Flow
 0.93 ― 0.97 0.97 0.86
Dividend Paid and CapEx Coverage Ratio
 1.01 ― 0.94 3.19 0.37
Capital Expenditure Coverage Ratio
 14.11 ― 34.20 36.75 7.36
Operating Cash Flow Coverage Ratio
 3.60 ― 2.71 4.15 1.32
Operating Cash Flow to Sales Ratio
 0.26 ― 0.23 0.42 0.14
Free Cash Flow Yield
5.87%―11.28%20.98%6.47%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 19.15 ― 10.09 8.60 9.84
Price-to-Sales (P/S) Ratio
 4.11 ― 2.01 1.93 1.81
Price-to-Book (P/B) Ratio
 6.09 ― 3.14 3.17 3.41
Price-to-Free Cash Flow (P/FCF) Ratio
 16.72 ― 8.87 4.77 15.44
Price-to-Operating Cash Flow Ratio
 16.04 ― 8.61 4.64 13.35
Price-to-Earnings Growth (PEG) Ratio
 0.19 ― -0.64 0.46 -0.36
Price-to-Fair Value
 6.09 ― 3.14 3.17 3.41
Enterprise Value Multiple
 12.15 ― 5.32 4.34 5.64
Enterprise Value
 135.61M ― 83.11M 77.78M 87.99M
EV to EBITDA
 12.43 ― 5.32 4.34 5.64
EV to Sales
 3.66 ― 1.68 1.54 1.68
EV to Free Cash Flow
 14.89 ― 7.41 3.82 14.35
EV to Operating Cash Flow
 13.83 ― 7.19 3.71 12.40
Tangible Book Value Per Share
 0.41 ― 0.52 0.50 0.45
Shareholders’ Equity Per Share
 0.42 ― 0.53 0.51 0.46
Tax and Other Ratios
Effective Tax Rate
 0.26 ― 0.27 0.27 0.27
Revenue Per Share
 0.60 ― 0.82 0.84 0.87
Net Income Per Share
 0.13 ― 0.16 0.19 0.16
Tax Burden
 0.74 ― 0.73 0.73 0.73
Interest Burden
 1.03 ― 0.99 0.98 0.98
Research & Development to Revenue
 0.00 ― <0.01 <0.01 <0.01
SG&A to Revenue
 0.24 ― 0.21 0.20 0.21
Stock-Based Compensation to Revenue
 0.00 ― 0.00 0.00 0.00
Income Quality
 1.19 ― 0.85 1.86 0.54
Currency in EUR